Orbits Oncology

What it does

Orbits Oncology is a pioneering company in the field of Artificial Intelligence and Health, utilizing AI to analyze human-like tumor models known as organoids. By developing predictive models on their digital platform, Orbits Oncology correlates in vitro organoid experiments with animal studies and clinical patient responses, revolutionizing the process of cancer drug development. Their proprietary AI algorithms offer superior accuracy and speed-to-insight compared to traditional methods, as evidenced by their publications, clinical trials, and pilot studies. As the first and only digital organoid analysis platform, Orbits Oncology's device-agnostic SAAS platform seamlessly integrates with various experimental and imaging systems, reducing barriers to adoption. By de-risking the translation of drug research from the lab to the clinic, Orbits Oncology accelerates the development and success rate of new cancer treatments.